Document is current
Any future updates will be listed below
-
Authors
Her, Jung Hyun https://orcid.org/0000-0002-1044-2430
Pretscher, Dominik https://orcid.org/0000-0002-2495-9860
Patra-Kneuer, Maria https://orcid.org/0000-0003-4656-0997
Schanzer, Juergen
Cho, Sung Yoo https://orcid.org/0000-0001-7785-1450
Hwang, Yu Kyeong https://orcid.org/0000-0001-5345-6691
Hoeres, Timm https://orcid.org/0000-0002-9494-0292
Boxhammer, Rainer
Heitmueller, Christina
Wilhelm, Martin
Steidl, Stefan https://orcid.org/0000-0003-0048-6859
Endell, Jan https://orcid.org/0000-0002-9790-4414
-
Funding
Funding for this research was provided by:
gc labcell corporation
morphosys ag
w. lutz stiftung
verein hilfe für krebskranke e.v
- License Information
-
More Information
Article History
Received: 30 June 2021
Accepted: 28 January 2022
First Online: 29 March 2022
Declarations
:
: MP, JS, RB, CH, SS, and JE are employees of MorphoSys AG, Planegg, Germany. SS owns shares of MorphoSys AG. GC LabCell and MorphoSys AG report a joint patent application.
: Not applicable.
: Not applicable.
: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Korea Research Institute of Bioscience and Biotechnology. Written informed consent was obtained from patients and healthy donors prior to the studies, in accordance with the Declaration of Helsinki.
